JP Patent

JP7756487B2 — ダパグリフロジンを用いて、駆出率が低下した心不全を治療する方法

Assigned to AstraZeneca AB · Expires 2025-10-20 · 1y expired

What this patent protects

Patent listed against Farxiga.

Drugs covered by this patent

Patent Metadata

Patent number
JP7756487B2
Jurisdiction
JP
Classification
—
Expires
2025-10-20
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.